West Pharmaceutical Services, Inc. Financials

Market Capitalization $19.89 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	40.73
Forward PE	35.23
Price to Sales TTM	$6.54
Price to Book MRQ	$6.47
Enterprise to Revenue	6.45
Enterprise to EBITDA	24.29

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	16.29%
Operating Margin	21.85%
Return on Assets TTM	10.22%
Return on Equity TTM	16.95%

Income Statement

Revenue TTM	$3,017,900,032
Revenue per Share TTM	$41.68
Quarterly Revenue Growth	7.70%
Gross Profit TTM	$1,073,699,968
EBITDA	$811,300,000
Net Income to Common TTM	$491,700,000
Diluted EPS TTM	$6.74
Quarterly Earnings Growth YoY	2.90%

Balance Sheet

Total Cash MRQ	$628,499,968
Total Cash per Share MRQ	$8.74
Total Debt MRQ	$
Total Debt to Equity MRQ	9.93
Current Ratio MRQ	2.87
Book Value per Share MRQ	$42.44

Cash Flow

Operating Cash Flow TTM	$693,800,000
Levered Free Cash Flow TTM	$251,187,504

WST Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	71,907,325
Float Shares	71,459,952
Avg 10 Volume	574,546
Avg 30 Volume	None
Shares Short	2,062,111
Short Ratio	3.09
Short % of Shares	3.77%
% Held by Insiders	0.59%
% Held by Institutions	97.77%

Stock Price Summary

Beta	1.17
Fifty Two Week Low	$187.43
Fifty Two Week High	$348.90
Fifty Two Week Change	-20.38%
Day 50 MA	$275.25
Day 200 MA	$242.95

Dividends and Splits

Forward Annual Dividend Rate	$0.88
Forward Annual Dividend Yield	0.32%
Trailing Annual Dividend Rate	$0.85
Trailing Annual Dividend Yield	0.31%
Payout Ratio	12.44%
Dividend Date	2026-02-04
Ex Dividend Date	2026-01-28
Last Split Factor
Last Split Date	2013-09-27